Florian Vogl

No más puestos en curso

Health Technology

Consumer Services

Perfil

Dr. Florian D.
Vogl was previously employed as a Chief Medical Officer by Immutep Ltd., a Chief Medical Officer by Cellestia Biotech AG, and a Head-Clinical Development Europe by Rainier Therapeutics, Inc. He received his doctorate degree from Ludwig-Maximilians-Universität München.

Antiguos cargos conocidos de Florian Vogl.

Empresas	Cargo	Fin
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Manufactures anti-cancer drugs	Director Técnico/Científico/I+D	01/05/2023
Rainier Therapeutics, Inc. Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer	Corporate Officer/Principal	01/12/2019
IMMUTEP LIMITED	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de Florian Vogl.

Formación de Florian Vogl.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Florian Vogl.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Immutep Ltd. Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics	Health Technology
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rainier Therapeutics, Inc. Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer	Health Technology
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Manufactures anti-cancer drugs	Health Technology